Differential Protein Expression Profile Between CD20 Positive and Negative Cells of the NCI-H929 Cell Line |
Geng, Chuan-Ying
(Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University)
Liu, Nian (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Yang, Guang-Zhong (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Liu, Ai-Jun (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Leng, Yun (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Wang, Hui-Juan (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Li, Li-Hong (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Wu, Yin (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Li, Yan-Chen (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) Chen, Wen-Ming (Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University) |
1 | Jakubikova J, Adamia S, Kost-Alimova M, et al (2011). Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood, 117, 4409-19. DOI ScienceOn |
2 | Khan MM, Mori M, Sakauchi F, et al (2006). Risk factors for multiple myeloma: evidence from the Japan Collaborative Cohort (JACC) study. Asian Pac J Cancer Prev, 7, 575-81. |
3 | Kyle RA, Gertz MA, Witzig TE, et al (2003). Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc, 78, 21-33. DOI ScienceOn |
4 | Kyle RA, Rajkumar SV(2008). Multiple myeloma. Blood, 111, 2962-72. DOI |
5 | Matsui W, Huff CA, Wang Q, et al (2004). Characterization of clonogenic multiple myeloma cells. Blood, 103, 2332-6. DOI ScienceOn |
6 | Matsui W, Wang Q, Barber JP, et al (2008). Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res, 68, 190-7. DOI ScienceOn |
7 | Paino T, Ocio EM, Paiva B, et al (2012). CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype. Haematologica, 97, 1110-4. DOI |
8 | Pilarski LM, Hipperson G, Seeberger K, et al (2000). Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood, 95, 1056-65. |
9 | Pilarski LM, Seeberger K, Coupland RW, et al (2002). Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice. Exp Hematol, 30, 221-8. DOI |
10 | Raab MS, Podar K, Breitkreutz I, et al (2009). Multiple myeloma. Lancet, 374, 324-39. DOI |
11 | Rajkumar SV (2011). Multiple myeloma: (2011) update on diagnosis, risk-stratification, and management. Am J Hematol, 86, 57-65. DOI |
12 | Yaccoby S, Barlogie B, Epstein J (1998). Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood, 92, 2908-13. |
13 | Yaccoby S, Epstein J (1999). The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood, 94, 3576-82. |
14 | Zhang Z, Zhang L, Hua Y, et al (2010). Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines. BMC Cancer, 10, 206-14. DOI |
15 | Brennan SK, Matsui W (2009). Cancer stem cells: controversies in multiple myeloma. J Mol Med (Berl), 87, 1079-85. DOI |
16 | Chiron D, Surget S, Maiga S, et al (2012). The peripheral CD138+ population but not the CD138-population contains myeloma clonogenic cells in plasma cell leukaemia patients. Br J Haematol, 156, 679-83. DOI |
17 | Hong D, Chen HX, Yu HQ, et al (2011). Quantitative proteomic analysis of dexamethasone-induced effects on osteoblast differentiation, proliferation, and apoptosis in MC3T3-E1 cells using SILAC. Osteoporos Int, 22, 2175-86. DOI |
18 | Hosen N, Matsuoka Y, Kishida S, et al (2012). CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. Leukemia, 26, 2135-41. DOI |
19 | Huff CA, Matsui W (2008). Multiple myeloma cancer stem cells. J Clin Oncol, 26, 2895-900. DOI |
![]() |